Revance Therapeutics (RVNC) Earnings
|
Expand Research on RVNC
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -9.5% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +20.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/25  |
Q424 | N/A | -$0.21 | N/A | N/A | $83.42M | = | N/A | N/A | ||
| 11/7/24 | Q324 | -$0.37 | -$0.27 | -$0.10 | $59.88M | $68.18M | = |  | | Details | |
| 11/6/24 |
Q324 | N/A | -$0.27 | N/A | N/A | $68.18M | = | N/A | N/A | ||
| 11/5/24 | Q324 | N/A | -$0.27 | N/A | N/A | $68.18M | = | N/A | N/A | ||
| 8/8/24 | Q224 | -$0.36 | -$0.36 | $0.00 | $65.3M | $66.3M | = | | | Details | |
| 5/9/24 | Q124 | -$0.58 | -$0.55 | -$0.03 | $51.94M | $59.39M | = | | | Details | |
| 2/28/24 | Q423 | -$0.62 | -$0.65 | +$0.03 | $69.8M | $62.38M | = | | | Details | |
| 11/8/23 | Q323 | -$1.63 | -$0.71 | -$0.92 | $56.8M | $59.29M | = | | | Details |
